SCH 497079
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SCH 497079, covering 2016-10-27 to 2017-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED) [Phase 1]